USPSTF Recommends Osteoporosis Screening for Women 65 Years and Older

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 14, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 14, 2025 -- The U.S Preventive Services Task Force (USPSTF) recommends osteoporosis screening to prevent osteoporotic fractures for all women aged 65 years and older and for postmenopausal women aged younger than 65 years at increased risk. These findings form the basis of a final recommendation statement published online Jan. 14 in the Journal of the American Medical Association.

Leila C. Kahwati, M.D., M.P.H., from the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, and colleagues reviewed evidence on osteoporosis screening. The researchers found that three randomized clinical trials and three systematic reviews reported benefits of screening in older, high-risk women. Compared with usual care, screening was associated with reductions in hip and major osteoporotic fractures (pooled relative risks, 0.83 and 0.94, respectively). Per 1,000 participants screened, the corresponding absolute risk differences were five to six fewer fractures.

Based on these findings, the USPSTF concludes with moderate certainty that osteoporosis screening to prevent osteoporotic fractures has moderate net benefit for women aged 65 years or older and for postmenopausal women younger than 65 years at increased risk (B recommendations). For preventing osteoporotic fracture in men, the evidence is insufficient and the balance of benefits and harms of screening cannot be determined (I recommendation).

"While screening can identify men who have osteoporosis, we need more evidence on whether or not screening and current treatments prevent fractures in men," task force vice chair John Wong, M.D., said in a statement. "The task force continues to call for more research in men and encourages anyone concerned about their bone health to speak with their clinician."

Evidence Report

Final Recommendation Statement

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-15 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords